Current reading list (January 2023)
We have been keeping an eye on the methods literature, and think people with an interest in the Bias Methods Group may be interested in the following articles published recently:
Alqaidoom Z, Nguyen PY, Awadh M, Page MJ. Impact of searching clinical trials registers in systematic reviews of pharmaceutical and non-pharmaceutical interventions: Reanalysis of meta-analyses. Res Synth Methods 2023;14:52-67.
Bobrovitz N, Noël K, Li Z, Cao C, Deveaux G, Selemon A, Clifton DA, Yanes-Lane M, Yan T, Arora RK. SeroTracker-RoB: a decision rule-based algorithm for reproducible risk of bias assessment of seroprevalence studies. Res Synth Methods 2023;doi: 10.1002/jrsm.1620.
Bridgman AC, McPhie ML, Voineskos SH, Chan AW, Drucker AM. Reporting of primary outcome measures and sample size calculations in randomized controlled trials in dermatology journals. J Am Acad Dermatol 2022;87:912-14.
Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, et al. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension. JAMA 2022;328:2345-56.
Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, et al. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension. JAMA 2022;328:2252-64.
Fabbri A, Mulinari S, Johansson M, Ghaur W, Khalil AM, Lundh A. Content and strength of conflict of interest policies at Scandinavian medical schools: a cross sectional study. BMC Med Educ 2022;22:812.
Malmsiø D, Frost A, Hróbjartsson A. A scoping review finds that guides to authors of protocols for observational epidemiological studies varied highly in format and content. J Clin Epidemiol 2022;doi: 10.1016/j.jclinepi.2022.12.012.
Munn Z, Stone J, Aromataris E, Klugar M, Sears K, Leonardi-Bee J, Barker TH. Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews. JBI Evid Synth 2022;doi: 10.11124/JBIES-22-00224.
Nejstgaard CH, Laursen DRT, Lundh A, Hróbjartsson A. Commercial funding and estimated intervention effects in randomized clinical trials: Systematic review of meta-epidemiological studies. Res Synth Methods 2022;doi: 10.1002/jrsm.1611.
Parker L, Bero L. Managing risk from conflicts of interest in guideline development committees. BMJ 2022;379:e072252.
Serghiou S, Axfors C, Ioannidis JPA. Lessons learnt from registration of biomedical research. Nat Hum Behav 2023;doi: 10.1038/s41562-022-01499-0.
Wang Y, Ghadimi M, Wang Q, Hou L, Zeraatkar D, Iqbal A, et al. Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues. J Clin Epidemiol 2022;152:218-25.
Former reading lists
The November 2022 reading list can be found here.
The December 2021 reading list can be found here.
The March 2021 reading list can be found here.
The July 2020 reading list can be found here.
The December 2019 reading list can be found here.
The March 2019 reading list can be found here.
The August 2018 reading list can be found here.
The February 2018 reading list can be found here.